Chris A. Rallis, Director at FENNEC PHARMACEUTICALS INC. (FENC), sold 1,390 shares at $10.90 ($15K) on 2023-12-26, disclosed to the SEC on 2023-12-28.
Open-market sale of $15k FENC by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FENC | SELL | 2025-07-07 | $10K | — | Filing → |
| FENC | SELL | 2025-04-11 | $7K | — | Filing → |
| FENC | SELL | 2025-02-14 | $8K | — | Filing → |